| 105932-8 |
Bacteria |
Prid |
Bronchial |
Pt |
Nom |
Culture |
|
ACTIVE |
Bacteria identified in Bronchial specimen by Culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
105932-8 |
|
Culture |
|
|
Observation |
|
|
|
0 |
Bacteria Bronch Cult |
|
|
|
N |
|
Bact; Bro; C&S; Cult; Cultures; Identity or presence; Microbiology; Nominal; Point in time; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105933-6 |
Bacteria |
Prid |
Surgical wound |
Pt |
Nom |
Anaerobic culture |
|
ACTIVE |
Bacteria identified in Surgical wound by Anaerobe culture |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
105933-6 |
|
Anaerobic culture |
|
|
Observation |
|
|
|
0 |
Bacteria Surgical wound Anaerobe Cult |
|
|
|
N |
|
Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cult; Cultures; Identity or presence; Microbiology; Nominal; Operative wound; Point in time; Random; Surg; Wnd |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105934-4 |
Regorafenib metabolite M4 |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
N-Desmethyl regorafenib [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
105934-4 |
|
|
|
|
Both |
|
|
|
0 |
N-Desmethyl regorafenib SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metab; Metabolites; Metb; N-Desmethyl regorafenib; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Regorafenibum; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 105935-1 |
Abemaciclib M2 metabolite |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Abemaciclib M2 metabolite [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
105935-1 |
|
|
|
|
Observation |
|
|
|
0 |
Abemaciclib M2 SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MDMB-CHMICA metabolite M2; Metab; Metabolites; Metb; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 105936-9 |
Abemaciclib M20 metabolite |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Abemaciclib M20 metabolite [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
105936-9 |
|
|
|
|
Both |
|
|
|
0 |
Abemaciclib M20 SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metab; Metabolites; Metb; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 105937-7 |
Sunitinib+N-Desethylsunitinib |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Sunitinib and N-Desethyl Sunitinib [Mass/volume] in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
DRUG/TOX |
|
105937-7 |
|
|
|
|
Both |
|
|
|
0 |
Sunitinib+NDsthylSntnb SrPl-m |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Sunitinib + N-Desethyl Sunitinib |
2.78 |
2.78 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 105938-5 |
DPYD gene.c.1236G>A |
PrThr |
Bld/Tiss |
Pt |
Ord |
Molgen |
|
ACTIVE |
DPYD gene.c.1236G>A [Presence] in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
105938-5 |
|
Molgen |
|
|
Both |
|
|
|
0 |
DPYD gene.c.1236G>A Bld/T Ql |
|
|
|
N |
|
Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; DPD; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105939-3 |
RUNX1 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
RUNX1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
105939-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
RUNX1 gene Mut Anl Bld/T |
|
|
|
N |
|
21q22.3; Acute myeloid leukemia 1; AML1; AML1-EVI-1; AMLCR1; Blood; CBF2alpha; CBFA2; EVI-1; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; PEBP2aB; PEBP2alpha; Point in time; Random; runt related transcription factor 1; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10594-0 |
Spermatozoa.tapering head/Spermatozoa |
NFr |
Semen |
Pt |
Qn |
|
|
ACTIVE |
Spermatozoa Tapering Head/Spermatozoa in Semen |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
FERT |
|
10594-0 |
|
|
|
|
Observation |
|
|
|
0 |
Sperm Tapering Head NFr Smn |
|
|
|
Y |
|
Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Tapering Head; URO; Urology |
2.79 |
1.0i |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 105940-1 |
DNMT3A gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
DNMT3A gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
105940-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
DNMT3A gene Mut Anl Bld/T |
|
|
|
N |
|
Blood; DNA methyltransferase 3 alpha; DNMT3A trgtd mut anlys; DNMT3A2; Identity or presence; M.HsaIIIA; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; TBRS; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105941-9 |
Multiple myeloma minimal residual disease analysis |
PrThr |
Bone mar |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Multiple myeloma minimal residual disease analysis [Presence] in Bone marrow by NAA with non-probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
105941-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
MM MRD anlyss Mar Ql NAA+non-probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; MM MRD anlyss; Molecular pathology; MOLPATH; Mult; Multi; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 105942-7 |
Tetrahydrocannabinol |
PrThr |
Saliva |
Pt |
Ord |
Confirm |
|
ACTIVE |
Tetrahydrocannabinol [Presence] in Saliva (oral fluid) by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105942-7 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
THC Sal Ql Cfm |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Marijuana; Nabilone; Oral fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sal; Screen; THC |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 105943-5 |
Tetrahydrocannabinol |
MCnc |
Saliva |
Pt |
Qn |
Confirm |
|
ACTIVE |
Tetrahydrocannabinol [Mass/volume] in Saliva (oral fluid) by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
105943-5 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
THC Sal Cfm-mCnc |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Delta(9)-THC; Delta-9-tetrahydrocannabinol; Dronabinol; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Marijuana; Mass concentration; Nabilone; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal; THC |
2.78 |
2.78 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 105944-3 |
ePHEDrine |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
ePHEDrine [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105944-3 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Ephedrin Ur Ql Cfm |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Ectasule; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 105945-0 |
Pseudoephedrine |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
Pseudoephedrine [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
105945-0 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Pseudoephedrine Ur Cfm-mCnc |
|
|
|
N |
|
Cenafed; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; Pseudoephed; QNT; Quan; Quant; Quantitative; Random; Sudafed; UA; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 105946-8 |
Pseudoephedrine |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Pseudoephedrine [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105946-8 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Pseudoephedrine Ur Ql Cfm |
|
|
|
N |
|
Cenafed; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Sudafed; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 105947-6 |
1-Hydroxymidazolam |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
1-Hydroxymidazolam [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105947-6 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
1OH-midazolam Ur Ql Cfm |
|
|
|
N |
|
1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Cfm; Chlonazepam metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; i; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 105948-4 |
7-Aminonitrazepam |
MCnc |
Urine |
Pt |
Qn |
Confirm |
|
ACTIVE |
7-Aminonitrazepam [Mass/volume] in Urine by Confirmatory method |
|
ADD |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
105948-4 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
7Aminonitrazepam Ur Cfm-mCnc |
|
|
|
N |
|
7-amino nitrazepam; 7Aminonitrazepam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Nitrazepam metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 105949-2 |
7-Aminonitrazepam |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
7-Aminonitrazepam [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105949-2 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
7Aminonitrazepam Ur Ql Cfm |
|
|
|
N |
|
7-amino nitrazepam; 7Aminonitrazepam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Nitrazepam metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 10595-7 |
Spermatozoa |
NCnc |
Semen |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Spermatozoa [#/volume] in Semen |
|
MIN |
DefinitionDescription |
|
|
10*9/L |
|
|
|
|
|
|
FERT |
|
10595-7 |
|
|
|
|
|
|
|
|
0 |
Deprecated Sperm # Smn |
|
|
|
|
|
#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; URO; Urology |
2.7 |
1.0i |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 105950-0 |
7-Aminoflunitrazepam |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
7-Aminoflunitrazepam [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105950-0 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
7Aminoflunitrazepam Ur Ql Cfm |
|
|
|
N |
|
7-amino flunitrazepam; 7Aminoflunitrazepam; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; GCMS; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 105951-8 |
Norketamine |
PrThr |
Urine |
Pt |
Ord |
Confirm |
|
ACTIVE |
Norketamine [Presence] in Urine by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105951-8 |
|
Confirm |
|
|
Observation |
|
|
|
0 |
Norketamine Ur Ql Cfm |
|
|
|
N |
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Ketamine metabolite; LC/MS/MS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
| 105952-6 |
O-nortramadol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
O-nortramadol [Mass/volume] in Urine |
|
ADD |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
105952-6 |
|
|
|
|
Observation |
|
|
|
0 |
O-nortramadol Ur-mCnc |
|
|
|
N |
|
Desmeth; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite; UA; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 105953-4 |
Pregabalin |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Pregabalin [Mass/volume] in Urine |
|
ADD |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
105953-4 |
|
|
|
|
Observation |
|
|
|
0 |
Pregabalin Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Lyrica; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
| 105954-2 |
Pregabalin |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Pregabalin [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
105954-2 |
|
|
|
|
Observation |
|
|
|
0 |
Pregabalin Ur Ql |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Lyrica; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn |
2.79 |
2.78 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: EXAMPLE_UNITS: Scale is Ord UCUM Unit is not required; |
0 |
